Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 1999, p. 175-177, Vol. 43, No. 1
Department of Biology, University of Leeds,
Leeds LS2 9JT, United Kingdom
Received 12 August 1998/Returned for modification 11 September
1998/Accepted 19 October 1998
The shikimate pathway presents an attractive target for malaria
chemotherapy. Three shikimic acid analogs exhibited different effects
on Plasmodium falciparum growth.
(6R)-6-Fluoro-shikimate and
(6S)-6-fluoro-shikimate inhibited growth (50% inhibitory
concentrations, 1.5 × 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Targeting the Shikimate Pathway in the Malaria
Parasite Plasmodium falciparum
5 and 2.7 × 10
4 M, respectively), whereas 2-fluoro-shikimate had no
effect. para-Aminobenzoic acid abrogated the inhibition,
demonstrating that the shikimate pathway was specifically targeted.
*
Corresponding author. Mailing address: Miall Building,
Clarendon Way, Department of Biology, University of Leeds, Leeds LS2 9JT, United Kingdom. Phone: 44-113 2332908. Fax: 44-113 2332882. E-mail: g.a.mcconkey{at}leeds.ac.uk.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»